par Halama, Niels;Zoernig, Inka;Berthel, Anna;Kahlert, Christoph;Klupp, Fee;Suarez-Carmona, Meggy
;Suetterlin, Thomas;Brand, Karsten;Krauss, Juergen;Lasitschka, Felix;Lerchl, Tina;Luckner-Minden, Claudia;Ulrich, Alexis;Koch, Moritz;Weitz, Juergen;Schneider, Martin;Buechler, Markus MW;Zitvogel, Laurence;Herrmann, Thomas T.R.;Benner, Axel;Kunz, Christina;Luecke, Stephan;Springfeld, Christoph;Grabe, Niels;Falk, Christine S;Jaeger, Dirk
Référence Cancer cell, 29, 4, page (587-601)
Publication Publié, 2016-04
;Suetterlin, Thomas;Brand, Karsten;Krauss, Juergen;Lasitschka, Felix;Lerchl, Tina;Luckner-Minden, Claudia;Ulrich, Alexis;Koch, Moritz;Weitz, Juergen;Schneider, Martin;Buechler, Markus MW;Zitvogel, Laurence;Herrmann, Thomas T.R.;Benner, Axel;Kunz, Christina;Luecke, Stephan;Springfeld, Christoph;Grabe, Niels;Falk, Christine S;Jaeger, DirkRéférence Cancer cell, 29, 4, page (587-601)
Publication Publié, 2016-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Halama, Niels; Zoernig, Inka; Berthel, Anna; Kahlert, Christoph; Klupp, Fee; Suarez-Carmona, Meggy; Suetterlin, Thomas; Brand, Karsten; Krauss, Juergen; Lasitschka, Felix; Lerchl, Tina; Luckner-Minden, Claudia; Ulrich, Alexis; Koch, Moritz; Weitz, Juergen; Schneider, Martin; Buechler, Markus MW; Zitvogel, Laurence; Herrmann, Thomas T.R.; Benner, Axel; Kunz, Christina; Luecke, Stephan; Springfeld, Christoph; Grabe, Niels; Falk, Christine S; Jaeger, Dirk |
| Informations sur la publication: | Cancer cell, 29, 4, page (587-601) |
| Statut de publication: | Publié, 2016-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adenocarcinoma -- drug therapy -- immunology -- secondary |
| Apoptosis -- drug effects | |
| Chemokine CCL5 -- antagonists & inhibitors -- biosynthesis -- metabolism | |
| Chemokines -- physiology | |
| Chemotaxis | |
| Clinical Trials, Phase I as Topic | |
| Clodronic Acid -- pharmacology | |
| Colorectal Neoplasms -- immunology | |
| Cyclohexanes -- pharmacology -- therapeutic use | |
| Humans | |
| Interferon-alpha -- metabolism | |
| Liver Neoplasms -- drug therapy -- immunology -- metabolism -- secondary | |
| Lung Neoplasms -- drug therapy -- secondary | |
| Lymphocytes, Tumor-Infiltrating -- immunology -- metabolism | |
| Macrophages -- drug effects -- metabolism | |
| Maraviroc | |
| Molecular Targeted Therapy | |
| NG-Nitroarginine Methyl Ester -- pharmacology | |
| Neoplasm Invasiveness | |
| Neoplasm Proteins -- antagonists & inhibitors -- physiology | |
| Phenylurea Compounds -- therapeutic use | |
| Pilot Projects | |
| Pyridines -- therapeutic use | |
| Receptors, CCR5 -- drug effects -- metabolism | |
| STAT3 Transcription Factor -- physiology | |
| Survival Analysis | |
| Triazoles -- pharmacology -- therapeutic use | |
| Tumor Cells, Cultured | |
| Tumor Microenvironment -- drug effects | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1535-6108 |
| info:doi/10.1016/j.ccell.2016.03.005 | |
| info:pii/S1535-6108(16)30087-3 | |
| info:pmid/27070705 |



